Canada Home Healthcare Market Size and Share
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 17.72 Billion |
| Market Size (2030) | USD 26.18 Billion |
| CAGR (2025 - 2030) | 8.11% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Canada Home Healthcare Market Analysis by Mordor Intelligence
The Canada Home Healthcare Market size is estimated at USD 17.72 billion in 2025, and is expected to reach USD 26.18 billion by 2030, at a CAGR of 8.11% during the forecast period (2025-2030).
The growth of the home healthcare market in Canada is driven by the rising geriatric population, favorable patient preferences, technological advancements, cost-efficiency, and the healthcare system's recognition of the value of home-based care. These factors are making home healthcare an increasingly integral part of the healthcare continuum in Canada, providing patients with more options for receiving high-quality care in their own homes.
Canada, like many developed countries, has an aging population. As people age, they often require more healthcare services. Home healthcare provides a convenient and cost-effective option for the geriatric population to receive medical care and support while remaining in the comfort of their homes. For instance, according to the data released by Statistics Canada in July 2024, approximately 2.4 million were at least 65 years of age in 2024 as compared to 2.3 million in 2023. Thus, a large proportion of geriatric people living in Canada is estimated to drive the demand for home healthcare services during the forecast period.
The high incidence of cardiovascular diseases is significantly driving the home healthcare market due to the increased demand for home healthcare services. The need for continuous monitoring and medication management for cardiovascular conditions often necessitates home healthcare. For instance, according to the article published in Elsevier in April 2024, approximately 90% of Canadians have at least one risk factor for cardiovascular disease (CVD), while one-third of the population had three or more risk factors in 2023. Therefore, the incidence of cardiovascular diseases is projected to continue increasing due to factors like an aging population and thereby driving the market's growth during the forecast period.
In addition, the high prevalence of hypertension in Canada underscores the urgent need for accessible and effective home healthcare solutions, such as telehealth consultations, remote monitoring devices, and personalized care plans, to manage blood pressure and overall health from the comfort of their homes. For instance, according to the data published by Statistics Canada in April 2023, hypertension affects almost one in four Canadian adults every year and is considered a leading risk factor for cardiovascular disease. Thus, the high prevalence of hypertension amongst Canadians is projected to drive the demand for home-based hypertension management solutions to reduce the burden of cardiovascular diseases on the healthcare system.
Moreover, the rising number of various product launches in Canada is set to drive market growth in the country during the forecast period. For instance, in July 2023, Vital Mobility Medical Supplies Inc. launched a ROBOOTER line of folding electric wheelchairs, including Robooter X40 Automatic Folding Electric Wheelchair and Robooter E40 Light-Weight Folding Electric Wheelchair in Canada. Thus, the availability of advanced, easy-to-use electric wheelchairs enhances accessibility and mobility for patients, making home healthcare an attractive and patient-centric option, thereby driving the market growth.
Therefore, factors such as the rising geriatric population, high prevalence of hypertension, and rising number of product launches in the country are projected to drive the Canadian home healthcare market growth. However, factors such as the stringent regulatory framework may impede the market growth during the study period.
Canada Home Healthcare Market Trends and Insights
The Therapeutic Segment is Expected to Show Significant Growth Over the Forecast Period
The therapeutic segment in the Canadian home healthcare market encompasses a range of healthcare equipment and interventions delivered in the home setting to address various medical conditions and aid in managing and treating chronic illnesses. Factors such as the rising prevalence of various chronic diseases such as arthritis, diabetes, cardiovascular diseases, and neurological diseases, the rising number of surgeries, surging government support, and the rising number of product launches are set to drive the therapeutic equipment segment growth during the forecast period.
The increasing number of individuals with diabetes necessitates advanced and accessible tools for monitoring, managing, and treating the condition at home, projected to drive the segment growth during the forecast period. For instance, as per the report published by the Diabetes Canada Organization in July 2023, approximately 30% of Canadians are suffering from diabetes or prediabetes, and 10% live with diagnosed diabetes. As per the same source, in June 2023, the Federal Government announced an investment of USD 1 million over three years to allow Diabetes Canada to implement the recommendations and strategies to eradicate diabetes in Canada.
Therefore, the high prevalence of diabetes in the country, coupled with the Canadian government's substantial investment in eradicating diabetes, underscores the importance of providing innovative and effective therapeutic instruments that empower patients to participate actively in their routine care, ultimately fueling the expansion of the therapeutic instrument segment within the home healthcare market in Canada.
Furthermore, the rising number of product launches is also projected to drive the segment growth during the forecast period. For instance, in February 2023, NovaResp Technologies Inc. developed an AI-enabled continuous positive airway pressure (CPAP) algorithm that will be compatible with any CPAP to predict apnea events during sleep in Canada. Similarly, in October 2023, DexCom, Inc. launched its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for Canadians with all types of diabetes ages two and older, including those who are pregnant.
Therefore, factors such as various chronic diseases such as diabetes, cardiovascular diseases, and neurological diseases and the active participation of prominent players in novel product launches are projected to drive segment growth during the forecast period.
The Respiratory Therapy Services Segment is Expected to Register a Significant Share of the Market Over the Forecast Period
The prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and sleep apnea is on the rise in Canada. This increased prevalence creates a growing demand for respiratory therapy services in the home healthcare sector. For instance, according to the Canadian Cancer Society, in May 2024, lung and bronchus cancer will be diagnosed in 32,100 Canadians, accounting for 13% of all new cancer cases in 2024. The increasing prevalence of chronic diseases, coupled with the aging population, is driving the demand for home healthcare services. This trend emphasizes the need for cost-effective, patient-centric care solutions, fostering growth in the home healthcare market.
Moreover, the increasing burden of chronic respiratory conditions, coupled with advancements in home healthcare technologies, is propelling market expansion. The adoption of portable nebulizers and smart inhalers has made asthma management more accessible and efficient for patients at home. For instance, according to an article published by Asthma Canada in November 2024, over 4.6 million individuals, spanning from infants to seniors, are grappling with asthma in Canada. This growing demand for personalized and convenient care solutions underscores the critical role of the home healthcare market in improving patient outcomes.
In addition, according to the Government of Canada 2023, Canada reported 2,217 cases of TB in 2023, translating to an incidence rate of 5.5 new TB cases per 100,000 people as compared to 5.1 new cases per 100,000 people in 2022. The home healthcare services enable patients to receive medical care and monitoring at home, reducing the burden on healthcare facilities and improving patient outcomes. Thus, the increasing prevalence of respiratory conditions in Canada, including COPD, TB, asthma, and severe respiratory diseases, is driving the growth of the home respiratory therapy service segment.
Therefore, the rising demand for personalized care, cost-effective treatment, improved patient comfort, and the integration of telehealth, preventative education, an aging population, and potential government support fuels this growth. Home-based respiratory therapy services offer a convenient and effective solution for managing respiratory conditions, aligning with the goal of enhancing patient outcomes and reducing healthcare costs in Canada's evolving healthcare landscape.
Therefore, the factors such as the rising prevalence of respiratory diseases and rising number of product launches are projected to accelerate the segment growth during the forecast period.
Competitive Landscape
The Canada Home Healthcare Market is moderately consolidated due to a few key companies dominating the market, including Bayshore HealthCare, Omron Healthcare, Drive DeVilbiss Healthcare, and Koninklijke Philips N.V., among others. The key players in the Canadian home healthcare market are actively engaging in key activities like partnerships, acquisitions, and collaborations to strengthen their market presence.
Canada Home Healthcare Industry Leaders
-
Omron Healthcare
-
Drive DeVilbiss Healthcare
-
Koninklijke Philips N.V.
-
ResMed
-
Bayshore HealthCare
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- April 2025: Insulet Corporation, a global player in tubeless insulin pump technology, has rolled out its Omnipod 5 in Canada. This development represents a significant advancement in the home healthcare market, as Omnipod 5 is Canada's inaugural tubeless, waterproof Automated Insulin Delivery (AID) System, tailored for individuals aged two and older with type 1 diabetes.
- December 2024: Mednow, a prominent digital health and pharmacy platform, collaborated with Integracare Inc., a frontrunner in private home healthcare services. Their collaboration targets a significant challenge in Canada: ensuring seniors can age safely and comfortably in their own homes. While medications are crucial for seniors' well-being at home, their complexity and the necessity to coordinate with multiple providers can lead to issues. These challenges include missed doses, harmful interactions, and heightened frustration for patients, families, and caregivers. Through their alliance with Integracare, they are planning to leverage technology and services to empower caregivers and clients in navigating these hurdles effectively.
Canada Home Healthcare Market Report Scope
As per the scope of the report, home health care (HHC) is intended to deliver various health services and equipment to patients at home. The HHC services are helpful when an individual requires a prolonged stay in healthcare facilities. These HHC services include equipment, therapies, diagnosis, and software to help physicians plan efficient treatment procedures in home-care settings. The Canada Home Healthcare Market is Segmented by Products and Services (Equipment, (Therapeutics, Diagnostics, and Mobility Care), Software and Services (Rehabilitation Services, Respiratory Therapy Services, Infusion Therapy Services, and Other Services). The report offers the value (in USD) for the above segments.
| Equipment | Therapeutic |
| Diagnostic | |
| Mobility Care | |
| Software | |
| Services | Rehabilitation Services |
| Respiratory Therapy Services | |
| Infusion Therapy Services | |
| Other Services |
| By Product and Services | Equipment | Therapeutic |
| Diagnostic | ||
| Mobility Care | ||
| Software | ||
| Services | Rehabilitation Services | |
| Respiratory Therapy Services | ||
| Infusion Therapy Services | ||
| Other Services | ||
Key Questions Answered in the Report
How big is the Canada Home Healthcare Market?
The Canada Home Healthcare Market size is expected to reach USD 17.72 billion in 2025 and grow at a CAGR of 8.11% to reach USD 26.18 billion by 2030.
What is the current Canada Home Healthcare Market size?
In 2025, the Canada Home Healthcare Market size is expected to reach USD 17.72 billion.
Who are the key players in Canada Home Healthcare Market?
Omron Healthcare, Drive DeVilbiss Healthcare, Koninklijke Philips N.V., ResMed and Bayshore HealthCare are the major companies operating in the Canada Home Healthcare Market.
What years does this Canada Home Healthcare Market cover, and what was the market size in 2024?
In 2024, the Canada Home Healthcare Market size was estimated at USD 16.28 billion. The report covers the Canada Home Healthcare Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Canada Home Healthcare Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Canada Home Healthcare Market Report
Statistics for the 2025 Canada Home Healthcare market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Canada Home Healthcare analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
